Global Interventional Oncology Market Analysis
According to Verified Market Research, the Global Interventional Oncology Market was valued at USD 1.78 Billion in 2018 and is projected to grow at a CAGR of 6.83% to reach USD 2.96 Billion by 2026, over the forecast period.
What is Interventional Oncology?
Interventional oncology deals with the diagnosis and treatment of cancer using minimally invasive procedures that are performed under image guidance. Interventional oncology is used to treat primary or metastatic cancer such as liver cancer, kidney cancer, lung cancer, bone cancer, prostate cancer, breast cancer, and pancreatic cancer. The procedures are carried out using guide accessories and instruments, including ablation electrodes, biopsy needles, and intravascular catheters that enable the treatment of a tumor situated in remote parts of the body.
Global Interventional Oncology Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and Restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Increasing demands for minimally invasive therapeutics is expected to fuel the market for Interventional Oncology. Lack of awareness among the population could be a potential restraint which can hamper the growth rate of Global Interventional Oncology Market.
Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The "Global Interventional Oncology Market" is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market. This can be of a great use in gaining knowledge about the cutting-edge technologies in the market.
Global Interventional Oncology Market Competitive Landscape
The "Interventional Oncology Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as Boston Scientific, Accuray, Medtronic, AtriCure, Baylis Medical, BTG, Alpinion Medical Systems, Terumo Corporation, AngioDynamics, and Merit Medical. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above mentioned players globally.
Global Interventional Oncology Market Segmentation, by Procedure
On the basis of Procedure, Interventional Oncology Market is segmented into:
• Radiation Therapy
• Ablation
• Particle Embolization
Global Interventional Oncology Market Geographic Scope
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Rest of Asia Pacific
• Latin America
o Brazil
• Rest of the World
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter's five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post sales analyst support
Customization of the Report
In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1 INTRODUCTION OF INTERVENTIONAL ONCOLOGY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 INTERVENTIONAL ONCOLOGY MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 INTERVENTIONAL ONCOLOGY MARKET, BY PROCEDURE
5.1 Overview
5.2 Radiation Therapy
5.2.1 Internal Radiation Therapy
5.2.2 External Radiation Therapy
5.3 Ablation
5.3.1 Cryoablation Therapy
5.3.2 Microwave Ablation Therapy
5.3.3 Radiofrequency Ablation
5.4 Particle Embolization
5.4.1 Drug-Eluting Beads
5.4.2 Radio-embolization
5.4.3 Microspheres
5.4.4 Polyvinyl Alcohol Particles
6 INTERVENTIONAL ONCOLOGY MARKET, BY GEOGRAPHY
6.1 Overview
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.2.3 Mexico
6.3 Europe
6.3.1 Germany
6.3.2 U.K.
6.3.3 France
6.3.4 Rest of Europe
6.4 Asia Pacific
6.4.1 China
6.4.2 Japan
6.4.3 India
6.4.4 Rest of Asia Pacific
6.5 Rest of the World
7 INTERVENTIONAL ONCOLOGY MARKET COMPETITIVE LANDSCAPE
7.1 Overview
7.2 Company Market Share
7.3 Vendor Landscape
7.4 Key Development Strategies
8 COMPANY PROFILES
8.1 Boston Scientific
8.2 Accuray
8.3 Medtronic
8.4 AtriCure
8.5 Baylis Medical
8.6 BTG
8.7 Alpinion Medical Systems
8.8 Terumo Corporation
8.9 AngioDynamics
8.10 Merit Medical
9 Appendix
9.1 Related Reports
Market Overview
The Asia Pacific Vascular Closure Devices Market is anticipated to experience substantial growth from 2024 to 2034. The market's expansion is fueled by advancements in vascular closure technologies, increasing prevalence of cardiovascular diseases, and the growing adopti...
Market Overview
The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...
Market Overview
The North America Vascular Closure Devices (VCD) Market is anticipated to witness significant growth from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, and advancements in vasc...
Market Overview
The Global Vascular Closure Devices Market is projected to grow substantially from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures and the rising demand for fast, efficient vascular closure solutions. In 2024, the market is v...
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
The Oncology Clinical Trial Monitor Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
Overview of the Global Virtual Oncology Market:
The report discusses everything a marketer requires before investing in the global Virtual Oncology Market during the forecast period 2023-2030. It provides detailed i...